Wal-Mart Stores Inc. (NYSE: WMT) has made a pretty big deal recently of its international expansion plans that would add sales and (hopefully) profit into the company's coffers. This is especially important as Wal-Mart's U.S. operations, while continuing to bring in sales, do so at lower rates every quarter. It's no surprise -- the $348 billion retailer is just too large to have any kind of huge growth in its largest market; it's tapped out to a degree. Solution? Get into the international marketplace as good as you can.
Now, Wal-Mart knows all about defeat overseas; it exited the South Korean and German markets in 2006 since it became clear those countries' citizens just weren't excited about buying from Wal-Mart. The company sold its operations in those two countries and did an about-face of sorts. It partnered with Trust-Mart in China and Bharti in India to get a foothold in those two countries -- where consumer spending is not doing anything but going up. Now, word on the street is that Wal-Mart may be entering the Russian market.
The founder of the Pyaterochka retail chain, Andrei Rogachev, wants to bring Wal-Mart to Russia apparently. According to Russian property development company Macromir, Wal-Mart has been talking since May about a possible entry into the Russian retail market. If Macromir and Wal-Mart reach an agreement soon, the global retailer will lease space in shopping complexes or new stores built just for Wal-Mart. These stores would be Supercenter-size, at roughly 200,000 square feet each. It's still a rumor that Wal-Mart will even enter the Russian market, but if it is serious about expanding international operations that are actually successful, Russia would make a great choice.
Last updated: February 09, 2012: 11:34 PM
Hot Stocks
DailyFinance Headlines
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
- Department Stores Reveal Top Selling Valentine's Gifts
Benzinga Headlines
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
- How to Profit From Surging Chinese Prices
- Credit Suisse is the Latest Swiss Bank to Disappoint
- Vodafone Misses Quarterly Revenue
TheFlyOnTheWall.com Headlines
- Week of 2/22 Fed Balance Sheet to be released at 16:30 ET
- Week of 2/13 Money Supply to be released at 16:30 ET
- Zumiez relocating ecommerce operations to Kansas
- AbitibiBowater announces termination of Fibrek's Shareholder Rights Plan
- Rockwell Medical 1.845M share registered direct offering priced at $9.50
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
- Department Stores Reveal Top Selling Valentine's Gifts
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal

